Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination
Status:
Active, not recruiting
Trial end date:
2022-02-15
Target enrollment:
Participant gender:
Summary
Investigating cytotoxicity of yellow fever specific CD8 T cells following YF-17D vaccination
and the following licensing of these epitope-specific CD8 T cells